自体脂肪移植在急性烧伤创面管理中的作用:一项随机对照研究
前瞻性、开放标签、单中心随机对照试验纳入100例浅度及深度真皮烧伤患者,随机分为自体脂肪移植方案组(A组)和传统换药组(B组)。A组总住院日显著降低(p<0.001),需进一步皮肤移植更少(p=0.003),挛缩形成更少(p<0.002),瘢痕质地改善(p<0.001)。
要点
- 自体脂肪移植方案组总住院日较传统换药组显著降低(p<0.001)。
- 自体脂肪移植方案组需进一步皮肤移植比例较传统换药组显著降低(p=0.003)。
- 自体脂肪移植方案组挛缩形成较传统换药组显著减少(p<0.002),瘢痕质地显著改善(p<0.001)。
核心结论
- 在急性烧伤创面治疗中,与传统方法相比,自体脂肪移植方案与临床显著改善相关,表现为住院时间更短、瘢痕或挛缩发生率更低、皮肤移植使用更少,并经系列照片和组织学评估确认。
研究设计与样本
- 前瞻性、开放标签、单中心随机对照临床试验,纳入100例浅度及深度真皮烧伤患者,随机分为A组(自体脂肪移植方案:单次注射自体脂肪移植后纳米脂肪敷料)和B组(传统方法:1%磺胺嘧啶银或其他外用药物系列换药)。
- 纳入标准为新入院烧伤患者,受累总体表面积(TBSA)10%-25%;排除标准包括TBSA<10%或>25%、皮下脂肪/筋膜/肌肉/骨骼缺失、吸入性烧伤、生殖器/会阴/肛周区域烧伤以及可能影响创面愈合或麻醉手术资格的合并症。
- 研究时间为2019年3月至2020年3月,临床试验注册号NCT03791710;结果通过两组样本的光学显微镜组织学分析和纳米脂肪的流式细胞术分析(间充质干细胞标志物CD90、CD44、CD45、CD73、CD34)确认。
主要发现
- A组较B组总住院日显著降低(p<0.001)。
- A组较B组需进一步皮肤移植显著减少(p=0.003)。
- A组较B组挛缩形成显著减少(p<0.002),瘢痕质地显著改善(p<0.001)。
- 流式细胞术分析显示纳米脂肪对CD90、CD73、CD44、CD45和CD34呈阳性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The use of fat grafting is being widely used for different indications one of which is wound healing. In this study we compare the use of autologous fat grafting (AFG) as a novel indication in acute burn wounds healing and burn scarring to the conventional methods of burn wound management both clinically and histologically. Several small observational studies demonstrated the effect of the AFG in healing of chronic wounds, different vascular ulcers or effect on scars yet no randomized controlled trial is available to compare its role with conventional methods. METHODS: The study was a prospective, open-label single center, randomized control clinical trial included 100 patients with superficial and deep dermal burns from March 2019 to March 2020 randomized to AFG protocol consisted of a single injection of autologous fat grafting then dressed with nano fat (Group A) or conventional methods of serial dressings with 1% silver sulphadiazine or other topical agents (Group B). Inclusion criteria included newly admitted burn patients with affected total body surface area (TBSA) (10%-25%) while exclusion criteria included burns patients with affected TBSA of< 10% or> 25%, or loss of subcutaneous fat, fascia, muscles and bones, inhalational burn, and burns in genitalia, perineum and peri-anal areas and co-morbidity(ies) that might affect wound healing or eligibility for anaesthesia and surgery. Also, results were confirmed by histological analysis for samples from both groups by light microscopic examination, and the nano-fat was subjected to flow cytometric analysis of the cluster of differentiation (CD) markers of mesenchymal stem cells markers CD 90, CD44, CD45, CD 73, and CD 34. (ClinicalTrials.gov Identifier: NCT03791710) RESULTS: We found a significant reduction in total hospital stay days (p = <0.001), less further skin grafting (p = 0.003), less contracture formation (p = <0.002) while scar texture improved (p = <0.001) in group A compared to group B. Flow cytometric analysis documented that the nano-fat was positive to CD 90, 73, 44, 45 and 34. CONCLUSION: In a comparison between AFG protocol to the conventional methods in the treatment of acute burn wounds, AFG protocol was associated with significant clinical improvement in the form of lower hospital stay time, lower incidence of scaring or contracture and lower skin grafting use which was confirmed by serial photographic and histological assessment.
引用
- Abouzaid AM, El Mokadem ME, Aboubakr AK, et al. Effect of autologous fat transfer in acute burn wound management: A randomized controlled study. Burns. 2021. PMID: 34906386. doi:10.1016/j.burns.2021.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。